Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00075829 · OUTCOME

Overall Survival (OS) for Standard Risk

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) · Source last updated 2021-11-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of patients
Interval / dispersion
95% Confidence Interval
Time frame
Years 1, 2, and 3

What was measured

The event is death from any cause, patients alive at the time of last observation are considered censored.

Analysis population: Patients that completed second transplant

Groups in this outcome

Auto-Auto Standard Risk

Tandem autologous transplant plus thalidomide/dexamethasone or observation for standard risk patients

Auto-Allo Standard Risk

Autologous transplant plus non-myeloablative allogeneic transplant for standard risk patients

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Auto-Auto Standard Risk366
Auto-Allo Standard Risk156

Reported measurements

1 year
Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Auto-Auto Standard Risk95Not reported9397Not reported
Auto-Allo Standard Risk91Not reported8795Not reported
2 years
Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Auto-Auto Standard Risk89Not reported8692Not reported
Auto-Allo Standard Risk85Not reported8091Not reported
3 years
Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Auto-Auto Standard Risk80Not reported7784Not reported
Auto-Allo Standard Risk77Not reported7284Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        93
        upper Limit
        97
        value
        95
      2. group Id
        OG001
        lower Limit
        87
        upper Limit
        95
        value
        91
    title
    1 year
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        86
        upper Limit
        92
        value
        89
      2. group Id
        OG001
        lower Limit
        80
        upper Limit
        91
        value
        85
    title
    2 years
  3. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        77
        upper Limit
        84
        value
        80
      2. group Id
        OG001
        lower Limit
        72
        upper Limit
        84
        value
        77
    title
    3 years
denoms
  1. counts
    1. group Id
      OG000
      value
      366
    2. group Id
      OG001
      value
      156
    units
    Participants
description
The event is death from any cause, patients alive at the time of last observation are considered censored.
dispersion Type
95% Confidence Interval
groups
  1. description
    Tandem autologous transplant plus thalidomide/dexamethasone or observation for standard risk patients
    id
    OG000
    title
    Auto-Auto Standard Risk
  2. description
    Autologous transplant plus non-myeloablative allogeneic transplant for standard risk patients
    id
    OG001
    title
    Auto-Allo Standard Risk
param Type
NUMBER
population Description
Patients that completed second transplant
reporting Status
POSTED
time Frame
Years 1, 2, and 3
title
Overall Survival (OS) for Standard Risk
type
SECONDARY
unit Of Measure
percentage of patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice